AACR centennial series: the biology of cancer metastasis: historical perspective.

Metastasis resistant to therapy is the major cause of death from cancer. Despite almost 200 years of study, the process of tumor metastasis remains controversial. Stephen Paget initially identified the role of host-tumor interactions on the basis of a review of autopsy records. His "seed and soil" hypothesis was substantiated a century later with experimental studies, and numerous reports have confirmed these seminal observations. An improved understanding of the metastatic process and the attributes of the cells selected by this process is critical for the treatment of patients with systemic disease. In many patients, metastasis has occurred by the time of diagnosis, so metastasis prevention may not be relevant. Treating systemic disease and identifying patients with early disease should be our goal. Revitalized research in the past three decades has focused on new discoveries in the biology of metastasis. Even though our understanding of molecular events that regulate metastasis has improved, the contributions and timing of molecular lesion(s) involved in metastasis pathogenesis remain unclear. Review of the history of pioneering observations and discussion of current controversies should increase understanding of the complex and multifactorial interactions between the host and selected tumor cells that contribute to fatal metastasis and should lead to the design of successful therapy.

[1]  A. Silvani,et al.  CXCL12, CXCR4 and CXCR7 expression in brain metastases , 2009, Cancer biology & therapy.

[2]  A. Barabasi,et al.  Cancer metastasis networks and the prediction of progression patterns , 2009, British Journal of Cancer.

[3]  Massimo Cristofanilli,et al.  A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. , 2009, The Journal of surgical research.

[4]  J. Talmadge,et al.  Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. , 2009, International immunopharmacology.

[5]  R. Virchow As Based upon Physiological and Pathological Histology , 2009 .

[6]  A. Varki,et al.  Molecular basis of metastasis. , 2009, The New England journal of medicine.

[7]  D. Noonan,et al.  Prediction of breast cancer metastasis by genomic profiling: where do we stand? , 2009, Clinical & Experimental Metastasis.

[8]  B. Rini,et al.  Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients , 2009, Clinical Cancer Research.

[9]  Ugo Del Monte,et al.  Does the cell number 10(9) still really fit one gram of tumor tissue , 2009 .

[10]  L. Bolund,et al.  Estimation of tumor heterogeneity using CGH array data , 2009, BMC Bioinformatics.

[11]  B. Rini,et al.  Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients , 2008, Clinical Cancer Research.

[12]  J. Harbour,et al.  Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling , 2008, Melanoma research.

[13]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[14]  G. Mundy The premetastatic niche , 2008 .

[15]  Lisa M. Coussens,et al.  Immune cells as mediators of solid tumor metastasis , 2008, Cancer and Metastasis Reviews.

[16]  A. Dimmler,et al.  The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.

[17]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[18]  D. Nolan,et al.  Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis , 2008, Science.

[19]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[20]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[21]  D. Tarin,et al.  Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications , 2007, Molecular oncology.

[22]  K. Coombes,et al.  Zonal heterogeneity for gene expression in human pancreatic carcinoma. , 2007, Cancer research.

[23]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[24]  S. Rafii,et al.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.

[25]  I. Fidler,et al.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.

[26]  I. Fidler,et al.  Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.

[27]  A. Dupuy,et al.  Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. , 2007, Journal of the National Cancer Institute.

[28]  P. Kearns,et al.  Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. , 2007, Blood.

[29]  Anne E Carpenter,et al.  The Spemann organizer gene, Goosecoid, promotes tumor metastasis , 2006, Proceedings of the National Academy of Sciences.

[30]  S. Rafii,et al.  Preparing the "soil": the premetastatic niche. , 2006, Cancer research.

[31]  Hong Zhang,et al.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas , 2006, Molecular Cancer.

[32]  Igor Jurisica,et al.  Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity , 2006, Clinical Cancer Research.

[33]  Ingo Fricke,et al.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. , 2006, Cancer research.

[34]  D. Tarin,et al.  Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis , 2006, International journal of cancer.

[35]  Gabriel Capellà,et al.  Genetic instability and divergence of clonal populations in colon cancer cells in vitro , 2006, Journal of Cell Science.

[36]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[37]  K. Hunter,et al.  Host genetics influence tumour metastasis , 2006, Nature Reviews Cancer.

[38]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[39]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[40]  Liang Cheng,et al.  Clonal origin of lymph node metastases in bladder carcinoma , 2005, Cancer.

[41]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[42]  C. Lewis,et al.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.

[43]  J. Talmadge,et al.  Hematopoietic progenitor cell mobilization in mice by sustained delivery of granulocyte colony-stimulating factor. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[44]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[45]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[46]  D. Tarin,et al.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.

[47]  D. Tarin,et al.  Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. , 2005, The American journal of pathology.

[48]  Silvia Benvenuti,et al.  Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. , 2005, The Lancet. Oncology.

[49]  D. Gabrilovich,et al.  STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion1 , 2005, The Journal of Immunology.

[50]  L. Trümper,et al.  Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.

[51]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[52]  E. Ruoslahti,et al.  Vascular zip codes in angiogenesis and metastasis. , 2004, Biochemical Society transactions.

[53]  Annuska M Glas,et al.  Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[55]  G. Dontu,et al.  Stem cells in normal breast development and breast cancer , 2003, Cell proliferation.

[56]  S. Evans,et al.  Tumor microvasculature as a barrier to antitumor immunity , 2003, Cancer Immunology, Immunotherapy.

[57]  D Hölzel,et al.  The process of metastasisation for breast cancer. , 2003, European journal of cancer.

[58]  Ed Roos,et al.  The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.

[59]  P. Gosling DORLAND’S ILLUSTRATED MEDICAL DICTIONARY , 2003, Australasian Chiropractic & Osteopathy.

[60]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[61]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[62]  G. Dranoff GM-CSF-secreting melanoma vaccines , 2003, Oncogene.

[63]  I. Fidler,et al.  Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population , 2003, Nature Genetics.

[64]  I. Fidler,et al.  Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. , 2003, Journal of the National Cancer Institute.

[65]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[66]  I. Fidler,et al.  The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.

[67]  Birgit Luber,et al.  Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.

[68]  Toru Watanabe,et al.  Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. , 2002, Anticancer research.

[69]  N. Stoecklein,et al.  Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer , 2002, The Lancet.

[70]  D. Larsimont,et al.  Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[71]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[72]  I. Fidler,et al.  Critical determinants of metastasis. , 2002, Seminars in cancer biology.

[73]  R. DePinho,et al.  Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. , 2002, Cancer cell.

[74]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[75]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[76]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[77]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[78]  Nicholas R. English,et al.  Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.

[79]  R. Ronca,et al.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.

[80]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[81]  D. Carbone,et al.  Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[82]  L. Ellis,et al.  Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. , 2000, The oncologist.

[83]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[84]  D. Carbone,et al.  Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[85]  T. Chao,et al.  Metaplastic carcinomas of the breast , 1999, Journal of surgical oncology.

[86]  A. Schäffer,et al.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. , 1999, The American journal of pathology.

[87]  M. Young,et al.  Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. , 1999, International journal of immunopharmacology.

[88]  S. Tsujitani,et al.  Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. , 1998, British Journal of Cancer.

[89]  D. Carbone,et al.  Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.

[90]  S. Rosenberg,et al.  Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. , 1998, Journal of immunology.

[91]  L. Liotta,et al.  Laser-capture microdissection: opening the microscopic frontier to molecular analysis. , 1998, Trends in genetics : TIG.

[92]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[93]  A. Kessinger,et al.  GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression , 1997, Bone Marrow Transplantation.

[94]  Y. Miyagi,et al.  Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. , 1997, Cancer research.

[95]  A. Schäffer,et al.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.

[96]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[97]  Mike Wilson,et al.  Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[99]  M. Toi,et al.  Quantitative analysis of vascular endothelial growth factor in primary breast cancer , 1996, Cancer.

[100]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[101]  Roland Holland,et al.  Age‐dependent growth rate of primary breast cancer , 1993, Cancer.

[102]  Bengt Lundgren,et al.  Breast carcinoma growth rate described by mammographic doubling time and S‐phase fraction. Correlations to clinical and histopathologic factors in a screened population , 1992, Cancer.

[103]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[104]  M. Kaminski,et al.  The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[105]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[106]  J. Talmadge,et al.  Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. , 1990, Journal of autoimmunity.

[107]  T. P. Pretlow,et al.  Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. , 1990, Cancer research.

[108]  P. Sloan,et al.  Spindle-cell carcinoma: a case report. , 1990, The British journal of oral & maxillofacial surgery.

[109]  H. Norris,et al.  Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. , 1989, Human pathology.

[110]  S. Paget The distribution of secondary growths in cancer of the breast. 1889. , 1989, Cancer metastasis reviews.

[111]  H. Jd,et al.  The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site. , 1989 .

[112]  G. Nicolson Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.

[113]  R. Kerbel,et al.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. , 1988, Cancer research.

[114]  R. Kerbel,et al.  Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo , 1988, Molecular and cellular biology.

[115]  I. Fidler,et al.  Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. , 1988, Cancer research.

[116]  G. Nicolson Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites , 1988, Cancer and Metastasis Reviews.

[117]  I. Fidler,et al.  Influence of organ microenvironment on pigmentation of a metastatic murine melanoma. , 1988, Cancer research.

[118]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[119]  B. Zbar,et al.  Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis. , 1987, Invasion & metastasis.

[120]  K. Tanaka,et al.  Evidence by cellular mosaicism for monoclonal metastasis of spontaneous mouse mammary tumors. , 1987, Journal of the National Cancer Institute.

[121]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.

[122]  I. Fidler,et al.  The biology of cancer metastasis and implications for therapy. , 1987, Current problems in surgery.

[123]  A. Hackett,et al.  MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCER , 1987, The Lancet.

[124]  B. Zbar,et al.  Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization. , 1987, Journal of the National Cancer Institute.

[125]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[126]  J E Talmadge,et al.  Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. , 1986, Cancer research.

[127]  I. Fidler,et al.  Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases. , 1986, Journal of the National Cancer Institute.

[128]  I. Fidler,et al.  Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. , 1986, Cancer research.

[129]  G. Nicolson,et al.  Organ specificity of metastatic tumor colonization is related to organ‐selective growth properties of malignant cells , 1986, International journal of cancer.

[130]  E. Hay,et al.  Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro. , 1986, Developmental biology.

[131]  R. Carter Principles of Metastasis , 1986, British Journal of Cancer.

[132]  S. Gordon,et al.  Biology of the Macrophage , 1986, Journal of Cell Science.

[133]  H. Smith,et al.  Monoclonal antibody that defines human myoepithelium. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[134]  I. Fidler Macrophages and metastasis--a biological approach to cancer therapy. , 1985, Cancer research.

[135]  D. Welch,et al.  Implications of tumor progression on clinical oncology , 1985, Clinical & Experimental Metastasis.

[136]  I. Fidler,et al.  Development and progression of karyotypic variability in melanoma K1735 following X-irradiation. , 1985, Cancer research.

[137]  I. Fidler,et al.  Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. , 1984, Cancer research.

[138]  D. Tarin,et al.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. , 1984, Cancer research.

[139]  R. Steele,et al.  A high macrophage content in human breast cancer is not associated with favourable prognostic factors , 1984, The British journal of surgery.

[140]  V. Ling,et al.  Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. , 1984, Science.

[141]  I. Fidler,et al.  A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. , 1984, Journal of the National Cancer Institute.

[142]  B. Geiger,et al.  Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. , 1984, Cancer research.

[143]  S. Kottaridis,et al.  Uncontrolled growth of tumour stromal fibroblasts in vitro. , 1983, Experimental cell biology.

[144]  I. Fidler,et al.  Lack of correlation between the progressive growth of spontaneous metastases and their content of infiltrating macrophages. , 1982, Journal of the Reticuloendothelial Society.

[145]  R. Fischer,et al.  Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. , 1982, British Journal of Cancer.

[146]  G Poste,et al.  Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[147]  I. Fidler,et al.  Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. , 1982, Journal of the National Cancer Institute.

[148]  J E Talmadge,et al.  Evidence for the clonal origin of spontaneous metastases. , 1982, Science.

[149]  I. Fidler,et al.  Cancer metastasis is selective or random depending on the parent tumour population , 1982, Nature.

[150]  G. Nicolson,et al.  Tumor metastasis is not due to adaptation of cells to a new organ environment. , 1982, Science.

[151]  E. Mayhew,et al.  Metastatic inefficiency in mice bearing B16 melanomas. , 1982, British Journal of Cancer.

[152]  I. Fidler,et al.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[153]  C. Bucana,et al.  Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. , 1981, Journal of the National Cancer Institute.

[154]  I. Fidler,et al.  Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[155]  I. Fidler,et al.  Macrophage content of metastatic and nonmetastatic rodent neoplasms. , 1981, Journal of immunology.

[156]  I. Fidler,et al.  Activation of rat alveolar macrophages to the tumoricidal state in the presence of progressively growing pulmonary metastases. , 1981, Cancer research.

[157]  E. M. Lawler,et al.  Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene‐induced sarcomas , 1980, International journal of cancer.

[158]  I. Fidler,et al.  Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.

[159]  I. Fidler,et al.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.

[160]  J. Talmadge,et al.  Role of NK cells in tumour growth and metastasis in beige mice , 1980, Nature.

[161]  D. Fournier,et al.  Growth rate of 147 mammary carcinomas , 1980, Cancer.

[162]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[163]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[164]  I. Hart The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.

[165]  Kerbel Rs Immunologic studies of membrane mutants of a highly metastatic murine tumor. , 1979 .

[166]  I. Fidler,et al.  Influence of immune status on the metastasis of three murine fibrosarcomas of different immunogenicities. , 1979, Cancer research.

[167]  M. Kripke,et al.  Speculations on the role of ultraviolet radiation in the development of malignant melanoma. , 1979, Journal of the National Cancer Institute.

[168]  A. Mantovani,et al.  Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity , 1978, International journal of cancer.

[169]  G. Nicolson,et al.  Selection and biologic properties of malignant variants of a murine lymphosarcoma. , 1978, Journal of the National Cancer Institute.

[170]  G. Nicolson,et al.  Specificity of arrest, survival, and growth of selected metastatic variant cell lines. , 1978, Cancer research.

[171]  I. Fidler,et al.  Tumor heterogeneity and the biology of cancer invasion and metastasis. , 1978, Cancer research.

[172]  I. Fidler,et al.  Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. , 1978, Cancer research.

[173]  S. Shackney,et al.  Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. , 1978, Annals of internal medicine.

[174]  E. Briles,et al.  Isolation and metastatic properties of detachment variants of B16 melanoma cells. , 1978, Journal of the National Cancer Institute.

[175]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[176]  L. Liotta,et al.  Degradation of basement membrane by murine tumor cells. , 1977, Journal of the National Cancer Institute.

[177]  R. Kerbel,et al.  An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas. , 1976, Journal of the National Cancer Institute.

[178]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[179]  S. Eccles,et al.  THE SIGNIFICANCE OF MACROPHAGES IN HUMAN AND EXPERIMENTAL TUMORS * , 1976, Annals of the New York Academy of Sciences.

[180]  I. Fidler,et al.  Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. , 1976, Cancer research.

[181]  M. S. Fisher,et al.  Immunologic parameters of ultraviolet carcinogenesis. , 1976, Journal of the National Cancer Institute.

[182]  G. Nicolson,et al.  Organ specificity of blood-borne tumour metastasis determined by cell adhesion? , 1975, Nature.

[183]  P. Gullino,et al.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.

[184]  S. Eccles,et al.  Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.

[185]  B. Morson,et al.  Evolution of cancer of the colon and rectum , 1974, Cancer.

[186]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[187]  B. Giovanella,et al.  Metastases of Human Melanomas Transplanted in “Nude” Mice , 1973 .

[188]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[189]  B. Fisher,et al.  The organ distribution of disseminated 51 Cr-labeled tumor cells. , 1967, Cancer research.

[190]  B. Fisher,et al.  The interrelationship of hematogenous and lymphatic tumor cell dissemination. , 1966, Surgery, gynecology & obstetrics.

[191]  T. Gasic,et al.  Removal of sialic acid from the cell coat in tumor cells and vascular endothelium, and its effects on metastasis. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[192]  P. Nowell,et al.  Differential growth of metastatic tumors in liver and lung; experiments with rabbit V2 carcinoma. , 1952, Cancer research.

[193]  J. Buss,et al.  Transpulmonary passage of tumor cell emboli. , 1952, Cancer research.

[194]  D. R. Coman Decreased Mutual Adhesiveness, a Property of Cells from Squamous Cell Carcinomas , 1944 .

[195]  Neoplastic Diseases: A Treatise on Tumours , 1928, The Indian Medical Gazette.

[196]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[197]  J. Cohnheim Ueber Entzündung und Eiterung , 1867, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[198]  S. Kasimir-Bauer Circulating Tumor Cells as Markers for Cancer Risk Assessment and Treatment Monitoring , 2012, Molecular Diagnosis & Therapy.

[199]  D. Peeper,et al.  Metastasis mechanisms. , 2009, Biochimica et biophysica acta.

[200]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[201]  Miriam K. Konkel,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.

[202]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[203]  I. Fidler,et al.  Growth in an organ microenvironment as a selective process in metastasis , 2005, Clinical & Experimental Metastasis.

[204]  C. Brigati,et al.  Tumors and inflammatory infiltrates: Friends or foes? , 2004, Clinical & Experimental Metastasis.

[205]  K. Malmberg,et al.  Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? , 2004, Cancer immunology, immunotherapy : CII.

[206]  I. Fidler,et al.  Tumor cell antigenicity, host immunity, and cancer metastasis , 2004, Cancer Immunology, Immunotherapy.

[207]  I. Bross,et al.  The metastatic spread of myeloma and leukemias in men , 2004, Virchows Archiv A.

[208]  I. Fidler,et al.  The Biology of Melanoma Brain Metastasis , 2004, Cancer and Metastasis Reviews.

[209]  N. Hanna Role of natural killer cells in control of cancer metastasis , 2004, Cancer and Metastasis Reviews.

[210]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[211]  Lurias,et al.  MUTATIONS OF BACTERIA FROM VIRUS SENSITIVITY TO VIRUS RESISTANCE’-’ , 2003 .

[212]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[213]  S. Goodison,et al.  Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[214]  René Bernards,et al.  A progression puzzle. , 2002, Nature.

[215]  D. Carbone,et al.  VEGF as a mediator of tumor-associated immunodeficiency , 2001, Immunologic research.

[216]  D. Newgreen,et al.  Epithelium-mesenchyme transition during neural crest development. , 1995, Acta anatomica.

[217]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[218]  B. S. Baker,et al.  Dosage compensation in Drosophila. , 1994, Annual review of genetics.

[219]  G. Opdenakker,et al.  Chemotactic factors, passive invasion and metastasis of cancer cells. , 1992, Immunology today.

[220]  M. Mareel,et al.  Biology of cancer invasion and metastasis. , 1992, Acta oto-rhino-laryngologica Belgica.

[221]  P. Nowell Chromosomal and molecular clues to tumor progression. , 1989, Seminars in oncology.

[222]  R. Virchow Cellular pathology. As based upon physiological and pathological histology. Lecture XVI--Atheromatous affection of arteries. 1858. , 1989, Nutrition reviews.

[223]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[224]  I. Fidler,et al.  Correlation between the in vitro interaction of tumor cells with an organ environment and metastatic behavior in vivo. , 1987, Invasion & metastasis.

[225]  L. Liotta Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[226]  G. Poste,et al.  Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. , 1986, Cancer treatment reports.

[227]  H. Strander Interferon treatment of human neoplasia. , 1986 .

[228]  S. Strober Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. , 1984, Annual review of immunology.

[229]  G. Nicolson,et al.  Cancer invasion and metastasis : biologic and therapeutic aspects , 1984 .

[230]  J. Folkman Angiogenesis: initiation and modulation. , 1983, Symposium on Fundamental Cancer Research.

[231]  D. Witiak,et al.  Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds. , 1982, Advances in pharmacology and chemotherapy.

[232]  G. Poste,et al.  On the genesis and regulation of cellular heterogeneity in malignant tumors. , 1982, Invasion & metastasis.

[233]  I. Fidler,et al.  In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes. , 1981, Journal of the National Cancer Institute.

[234]  E. Grundmann,et al.  Metastatic tumor growth , 1980 .

[235]  R. Kerbel Immunologic studies of membrane mutants of a highly metastatic murine tumor. , 1979, The American journal of pathology.

[236]  E. Sugarbaker,et al.  Cancer metastasis: a product of tumor-host interactions. , 1979, Current problems in cancer.

[237]  I. Fidler Biological behavior of malignant melanoma cells correlated to their survival in vivo. , 1975, Cancer research.

[238]  P. Alexander,et al.  The macrophage content of some human tumours. , 1975, Cancer letters.

[239]  B. Giovanella,et al.  Brief communication: metastases of human melanomas transplanted in "nude" mice. , 1973, Journal of the National Cancer Institute.

[240]  I. J. Fidler Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. , 1970, Journal of the National Cancer Institute.

[241]  E. Klein Immediate transformation of solid into ascites tumors; studies on a mammary carcinoma of an inbred mouse strain. , 1955, Experimental cell research.

[242]  Makoto Takahashi An experimental study of metastasis , 1915 .